How to Choose an Antibody for Research
A practical guide to choosing primary and secondary antibodies by target, application, species, clonality, conjugation, validation evidence and supplier transparency.
Buying an antibody can look deceptively simple. Search for the target, choose a product that lists your application and species, and place the order. In practice, two antibodies against the same protein can perform very differently because their epitopes, host species, clonality, formulation, validation evidence and manufacturing history are not the same.
A stronger purchasing decision starts with the experiment rather than the brand. This guide explains what to check before buying a research antibody, how to compare monoclonal, polyclonal and recombinant formats, what meaningful validation evidence looks like, and how to select secondary antibodies without creating avoidable background or detection problems.
Start with the experiment, not the antibody brand
The most useful first question is not “Which supplier should I buy from?” It is “What does this antibody need to do in my experiment?”
Before comparing products, define the target protein, sample type, species, experimental application and whether the target is expected to be native, denatured, fixed, intracellular or surface expressed. Those details determine which validation data is actually relevant.
Target
Confirm protein identity, isoform, expected molecular weight and any important post translational modification or epitope requirement.
Application
Determine whether the antibody is needed for WB, ELISA, IHC, IF, flow cytometry, IP, ChIP or another workflow.
Species and sample
Check experimentally supported reactivity for your species and consider whether the evidence comes from a relevant tissue, cell line or sample matrix.
Choose an antibody by application
Antibodies are exposed to very different conditions across common research methods. Denaturation, fixation, antigen retrieval, permeabilisation and native protein interactions can all affect antibody binding.
| Application | What to check | Useful evidence |
|---|---|---|
| Western blot | Expected molecular weight, reducing conditions, sample species and lysate type | Correct band position, relevant positive control and preferably negative or KO/KD comparison |
| ELISA | Direct, indirect or sandwich format, sample matrix and required sensitivity | Assay specific performance, dynamic range, cross reactivity and matched pair data where relevant |
| IHC | FFPE or frozen tissue, antigen retrieval method and tissue relevance | Representative tissue staining with appropriate controls and localisation consistent with biology |
| IF / ICC | Fixation method, permeabilisation and expected subcellular localisation | Cell or tissue images with relevant controls and clear signal to background |
| Flow cytometry | Surface or intracellular target, fixation and fluorophore compatibility | Validated cell type, gating controls and appropriate isotype or biological controls |
| IP / ChIP | Native binding, bead compatibility and downstream detection strategy | Target enrichment under relevant lysis conditions and suitable controls |
Monoclonal, polyclonal or recombinant antibody?
Each antibody format has different strengths. The best choice depends on the experiment and the importance of specificity, signal strength, reproducibility and long term supply.
| Format | Recognition | Lot consistency | Typical advantage | Key consideration |
|---|---|---|---|---|
| Monoclonal | Single epitope | Generally good | Defined specificity and consistent clone identity | Performance can be affected if the relevant epitope is masked or altered |
| Polyclonal | Multiple epitopes | More variable between lots | Potentially strong signal and tolerance of some epitope variation | Lot changes can alter performance and background |
| Recombinant monoclonal | Sequence defined epitope recognition | High when produced from the same sequence | Long term reproducibility and sequence defined manufacture | Still requires application specific validation |
| Antibody fragments | Format dependent | Production dependent | Reduced Fc related interactions and smaller molecular size | Detection strategy may differ from full length IgG |
| Conjugated antibody | Depends on parent antibody | Depends on antibody and conjugation | Direct detection without a secondary antibody | Fluorophore or enzyme must match the detection platform |
Seven things to check before buying a research antibody
- 1. Target and immunogenIs the target clearly identified, and is enough information provided about the immunogen or epitope to assess relevance?
- 2. Application evidenceIs your intended application supported by experimental data rather than simply listed?
- 3. Species reactivityWas reactivity experimentally tested in your species, or only predicted from sequence homology?
- 4. Clonality and clone IDFor monoclonals, is the clone clearly identified so that the reagent can be traced and compared?
- 5. Positive and negative controlsDoes the validation include biologically relevant controls, including KO/KD or non expressing samples where appropriate?
- 6. Supplier transparencyCan you determine who manufactures the antibody and who owns the validation and quality control data?
- 7. Storage and handlingAre storage temperature, formulation, shelf life and freeze thaw guidance clear enough for routine laboratory use?
What does good antibody validation evidence look like?
Validation should demonstrate performance in the context in which the antibody will be used. A production QC test or binding assay can be useful, but it does not automatically establish suitability for Western blot, IHC, flow cytometry or another application.
Antibody datasheet red flags
A datasheet does not need to contain every possible experiment, but it should provide enough information to judge whether the antibody is suitable for your intended use.
- Applications are listed without representative experimental evidence.
- Species reactivity is predicted only, with no indication of experimental confirmation.
- A monoclonal antibody is sold without a clear clone identifier.
- The manufacturer or original source is unclear.
- Positive control information is vague or unrelated to the stated target.
- Storage, formulation or recommended working conditions are missing.
- Validation images are shown without enough experimental context to interpret them.
How to choose a secondary antibody
Secondary antibodies bind the primary antibody and provide the detection signal. A mismatch at this stage can create background, weak signal or complete assay failure even when the primary antibody is suitable.
Check the primary antibody host species first. A rabbit primary generally requires an anti rabbit secondary, while a mouse primary requires an anti mouse secondary. Then consider isotype, cross adsorption and the detection label required for the experiment.
- HRP or AP: commonly used for enzyme based detection workflows.
- Fluorescent conjugates: used for IF, imaging and flow cytometry where direct fluorescence detection is required.
- Pre absorbed secondaries: useful when reducing unwanted cross reactivity against other species is important.
- F(ab')₂ secondary fragments: may help reduce Fc receptor related binding in some cell based workflows.
Why antibody supplier transparency matters
The company selling an antibody is not always the organisation that originally developed or manufactured it. For researchers, that distinction matters because manufacturing ownership can affect traceability, continuity of supply, access to lot history and the ability to understand where validation data originated.
Before relying on a reagent for a long running programme, it is worth asking whether the supplier can clearly explain the manufacturing source, quality control route, clone identity, validation ownership and lot continuity.
ABMIUM uses supplier and documentation review to help researchers distinguish between product availability and meaningful evidence. Where an ABMIUM Verified™ or ABMIUM Validated™ designation is shown, the relevant product or supplier has been assessed against the applicable ABMIUM framework rather than receiving the designation simply because it is listed on the marketplace.
Antibody selection FAQs
Which antibody type is best for Western blot?
There is no single format that is always best. Prioritise evidence that the antibody recognises the expected target band under conditions similar to your experiment. Monoclonal, polyclonal and recombinant antibodies can all be suitable when appropriately validated.
Is a monoclonal antibody always more specific than a polyclonal antibody?
Monoclonal antibodies recognise a single epitope, which gives a defined binding profile, while polyclonal antibodies recognise multiple epitopes. Actual experimental specificity still depends on the antibody, target and assay conditions, so the validation data remains important.
Can predicted species reactivity be trusted?
Sequence similarity can help estimate whether cross species binding is plausible, but predicted reactivity is not equivalent to experimental validation. For critical experiments, look for data generated in the species or sample type you intend to use.
What is the difference between ABMIUM Verified™ and ABMIUM Validated™?
ABMIUM Verified™ reflects the applicable supplier, documentation and provenance review framework. ABMIUM Validated™ is reserved for products with additional validation evidence supporting the stated research application under the relevant ABMIUM criteria.
What should I do if I cannot find an antibody for my target?
Start with the target sequence, species and intended application. ABMIUM can review available catalogue options or discuss a custom antibody route where an appropriate off the shelf reagent is not available.
Need help choosing an antibody?
Send ABMIUM your target, species, application and sample type. We can help narrow suitable research antibody options and review the available evidence before you commit to a purchase.
Research Use Only. Products and services described in this guide are not intended for diagnostic, therapeutic or clinical use.